Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical Industries L Up 24.16% To $8.90 After Earnings Beat
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha
Teva Shares Spike After Q1 Earnings Beat, Full Year Forecast Boost - TheStreet
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
TEVA Stock | Teva Pharmaceutical Industries Ltd Q3 2021 Earnings Call - YouTube
Teva Pharmaceutical beats Q4 earnings, sales estimates - Drug Delivery Business
Earnings season continues: BMS revenue inches up, Teva lowers outlook
TEVA PHARMACEUTICAL INDUSTRIES LIMITED TEVA EPS ANALYSIS
Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool
Teva Pharmaceutical: Earnings Trends and Recent Developments
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
TEVA Stock | Teva Pharmaceuticals Q2 2020 Earnings Call - YouTube
Earnings Preview: What To Expect From Teva Pharmaceutical On Thursday
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva soars after earnings beat, increased guidance - TheStreet
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror – PharmaLive
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva Pharmaceutical revenue 2006-2021 | Statista
Teva gains on earnings beat
